New and recently funded Medical Startups
1
Country: USA | Funding: $57M
Signos offers continuous data and recommendations designed to drive healthy and sustained weight loss.
Signos offers continuous data and recommendations designed to drive healthy and sustained weight loss.
2
Country: USA | Funding: $37.1M
Triomics uses GenAI to help cancer centers streamline trial enrollments, quality improvement projects, and healthcare operations.
Triomics uses GenAI to help cancer centers streamline trial enrollments, quality improvement projects, and healthcare operations.
3
Country: USA | Funding: $515M
Truveta is a healthcare data platform that provides electronic health records data for scientific research. Truveta's language model primarily extracts data from unstructured notes generated during patient care. This includes treatment progress notes, nursing assessments, procedure/surgery reports, referrals, discharge summaries, imaging reports, and more. The language model generates clinical concepts by linking the notes to structured data, enabling robust research in a variety of therapeutic areas, including cardiovascular disease, metabolic disease, oncology, neurology, hepatology, pulmonology, and rare diseases.
Truveta is a healthcare data platform that provides electronic health records data for scientific research. Truveta's language model primarily extracts data from unstructured notes generated during patient care. This includes treatment progress notes, nursing assessments, procedure/surgery reports, referrals, discharge summaries, imaging reports, and more. The language model generates clinical concepts by linking the notes to structured data, enabling robust research in a variety of therapeutic areas, including cardiovascular disease, metabolic disease, oncology, neurology, hepatology, pulmonology, and rare diseases.
4
Country: Germany
MediEEZI is a clinical operating system/ecosystem that captures, structures, and automatically optimizes medical processes in real time. MediEEZI does not replace individual processes, but rather creates an integrated infrastructure that unites care, resources, and economics into a single model. This transforms fragmented IT into a self-learning clinical AI core that controls and continuously improves the entire care pathway
MediEEZI is a clinical operating system/ecosystem that captures, structures, and automatically optimizes medical processes in real time. MediEEZI does not replace individual processes, but rather creates an integrated infrastructure that unites care, resources, and economics into a single model. This transforms fragmented IT into a self-learning clinical AI core that controls and continuously improves the entire care pathway
5
Country: Australia
IntuScribe is building a Clinical Intelligence Engine that masters your voice and synthesizes pure clinical reality. Unlike most AI scribes that offer basic "tone" prompts IntuScribe's technology mathematically maps clinic's unique documentation style across five distinct neural dimensions. By passively analyzing edits over time, the engine calibrates the perfect balance of Density, Register, Stance, Empathy, and Logic. In result notes sound unmistakably.
IntuScribe is building a Clinical Intelligence Engine that masters your voice and synthesizes pure clinical reality. Unlike most AI scribes that offer basic "tone" prompts IntuScribe's technology mathematically maps clinic's unique documentation style across five distinct neural dimensions. By passively analyzing edits over time, the engine calibrates the perfect balance of Density, Register, Stance, Empathy, and Logic. In result notes sound unmistakably.
6
Country: USA | Funding: $315.3M
ShiftMed develops workforce management platform for healthcare and a job search app for nurses. The startup claims the platform can reduce the number of temporary contracts by connecting healthcare organization with local nurses working on a W-2 contract and providing direct hiring from its contract-free pool with no conversion fees (which brings savings of up to $300 per shift thanks to intelligent workforce management). Healthcare providers can create a custom branded mobile app that gives nursing team job flexibility and ensures seamless scheduling and shift fulfillment.
ShiftMed develops workforce management platform for healthcare and a job search app for nurses. The startup claims the platform can reduce the number of temporary contracts by connecting healthcare organization with local nurses working on a W-2 contract and providing direct hiring from its contract-free pool with no conversion fees (which brings savings of up to $300 per shift thanks to intelligent workforce management). Healthcare providers can create a custom branded mobile app that gives nursing team job flexibility and ensures seamless scheduling and shift fulfillment.
7
Country: USA | Funding: $371.5M
Eargo produces hearing aids for adults with mild to moderate high-frequency hearing loss. They work well for those who require greater clarity rather than loudness in changing environment (Eargos automatically optimize your sound environment as you move between rooms). They are rechargeable, invisible and quite comfortable thanks to their complete fit within the ear canal. You can order hearing aids online after completing a clinically validated online hearing test. Then, using the Sound Match app, you can personalize your hearing aids to suit the unique hearing preferences of each ear. Acquired by LXE Hearing
Eargo produces hearing aids for adults with mild to moderate high-frequency hearing loss. They work well for those who require greater clarity rather than loudness in changing environment (Eargos automatically optimize your sound environment as you move between rooms). They are rechargeable, invisible and quite comfortable thanks to their complete fit within the ear canal. You can order hearing aids online after completing a clinically validated online hearing test. Then, using the Sound Match app, you can personalize your hearing aids to suit the unique hearing preferences of each ear. Acquired by LXE Hearing
8
Country: USA | Funding: $443.6M
Spero Therapeutics develops medications for patients suffering from rare diseases and multidrug-resistant bacterial infections. Its lead drug, the antibiotic Tebipenem HBr, is an oral carbapenem being developed for the treatment of complicated urinary tract infections, including pyelonephritis. If approved, Tebipenem, which has already successfully completed Phase 3 clinical trials, will be the first oral carbapenem for the treatment of this disease. Carbapenems are an important subclass of antibiotics for the treatment of infections caused by drug-resistant Gram-negative bacteria. Carbapenems have become the standard of care for many infections caused by multidrug-resistant Gram-negative bacteria, but are currently only available as intravenous formulations for this indication.
Spero Therapeutics develops medications for patients suffering from rare diseases and multidrug-resistant bacterial infections. Its lead drug, the antibiotic Tebipenem HBr, is an oral carbapenem being developed for the treatment of complicated urinary tract infections, including pyelonephritis. If approved, Tebipenem, which has already successfully completed Phase 3 clinical trials, will be the first oral carbapenem for the treatment of this disease. Carbapenems are an important subclass of antibiotics for the treatment of infections caused by drug-resistant Gram-negative bacteria. Carbapenems have become the standard of care for many infections caused by multidrug-resistant Gram-negative bacteria, but are currently only available as intravenous formulations for this indication.
9
Country: USA
SAIVA AI is a clinical intelligence platform redefining how long-term post-acute care teams identify risk and take action sooner. Built exclusively for LTPAC, our AI-powered solutions detect early signs of patient decline, recommend timely clinical interventions, and help nursing and therapy teams move from reactive, fragmented data to proactive, coordinated care.
SAIVA AI is a clinical intelligence platform redefining how long-term post-acute care teams identify risk and take action sooner. Built exclusively for LTPAC, our AI-powered solutions detect early signs of patient decline, recommend timely clinical interventions, and help nursing and therapy teams move from reactive, fragmented data to proactive, coordinated care.
10
Country: USA | Funding: $261.3M
Impel Pharmaceuticals has created FDA-approved nasal spray Trudhesa for the relief of acute migraine attacks with or without aura in adults. Trudhesa gently delivers dihydroergotamine mesylate - therapeutic agent, quickly into the bloodstream through the vascularized upper nasal space. It bypasses the intestines and potential absorption issues, providing rapid, long-lasting, and consistent relief. Impel also developed its proprietary Precision Olfactory Delivery drug delivery technology, which targets the vascularized upper nasal space. Its clinical studies have demonstrated rapid absorption and consistent bioavailability, as well as ease of use for patients, physicians, and caregivers.
Impel Pharmaceuticals has created FDA-approved nasal spray Trudhesa for the relief of acute migraine attacks with or without aura in adults. Trudhesa gently delivers dihydroergotamine mesylate - therapeutic agent, quickly into the bloodstream through the vascularized upper nasal space. It bypasses the intestines and potential absorption issues, providing rapid, long-lasting, and consistent relief. Impel also developed its proprietary Precision Olfactory Delivery drug delivery technology, which targets the vascularized upper nasal space. Its clinical studies have demonstrated rapid absorption and consistent bioavailability, as well as ease of use for patients, physicians, and caregivers.
